Targeting argininosuccinate synthetase negative melanomas using combination of arginine degrading enzyme and cisplatin

Loss of argininosuccinate synthetase (ASS) expression in melanoma makes these tumor cells vulnerable to arginine deprivation. Pegylated arginine deiminase (ADI-PEG20) which degrades arginine to citrulline and ammonia has been used clinically and partial responses and stable disease have been noted w...

Descripción completa

Detalles Bibliográficos
Autores principales: Savaraj, Niramol, Wu, Chunjing, Li, Ying-Ying, Wangpaichitr, Medhi, You, Min, Bomalaski, John, He, Wei, Kuo, Macus Tien, Feun, Lynn G.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Impact Journals LLC 2015
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4467438/
https://www.ncbi.nlm.nih.gov/pubmed/25749046

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4467438/
https://www.ncbi.nlm.nih.gov/pubmed/25749046

Ejemplares similares